AVANZ Cupressus Immunotherapy

· ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVANZ Cupressus Immunotherapy, covering 2015-01-06 to 2015-01-06. Get the full timeline:

Most recent: Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy [Phase 2]